Skip to main content
Premium Trial:

Request an Annual Quote

CBI and CFG to Co-market Their Products, Plan to Seek Joint Contracts

NEW YORK, Feb. 22 (GenomeWeb News) - Commonwealth Biotechnologies and the Center for Functional Genomics announced today that the will co-market their respective services.


Under the deal, CBI will have access to CFG transgenics and microarray instrumentation, while CFG will be able to support clients requiring GLP research for US Food and Drug Administration submission, CBI told GenomeWeb News.


The partners also plan to apply jointly for research contracts, said CBI chairman Richard Freer.


Financial details were not released.